California Pacific Medical Center, San Francisco, USA.
Dermatol Ther. 2013 Jul-Aug;26(4):347-53. doi: 10.1111/dth.12015.
Many women of childbearing age use prescription and non-prescription medications. Therefore, patients need to be counseled regarding the potential teratogenicity of medications if they are, or could become, pregnant. In this editorial, the present authors will explain the three advantages of the evidence-based medicine system when compared with the US Food and Drug Administration system for medication risk classification in pregnancy. The present authors will also comment on medication use during lactation and provide resources on medication use during pregnancy and lactation for clinicians and their patients.
许多育龄妇女使用处方和非处方药物。因此，如果患者已经怀孕或可能怀孕，就需要对药物的潜在致畸性进行咨询。在这篇社论中，作者将解释与美国食品和药物管理局（FDA）妊娠药物风险分类系统相比，循证医学系统的三大优势。作者还将对哺乳期用药进行评论，并为临床医生及其患者提供妊娠和哺乳期用药资源。
